Who
Shane J. Schaffer
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Cingulate.
In numbers
- Trades disclosed
- 29
- Buys
- 5
- Sells
- 0
- Bought
- $94K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 7 Dec 2021
- Last trade
- 16 Jul 2026
- Last filed
- 20 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —197,650 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —97,350 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —197,650 at $0.00 | filing |
| 16 Jul 2026filed 20 Jul 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —97,350 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code A | —6,862 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code F | —2,959 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code A | —6,862 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | CING CingulateBiotechnology | SEC FORM 4 Code F | —2,959 at $0.00 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING CingulateBiotechnology | SEC FORM 4 Bought | $34K6,809 at $5.04 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $5455,447 at $0.10 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $5455,447 at $0.10 | filing |
| 6 Feb 2026filed 10 Feb 2026 | CING CingulateBiotechnology | SEC FORM 4 Bought | $34K6,809 at $5.04 | filing |
| 7 Jul 2025filed 9 Jul 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —199,500 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —70,489 at $0.00 | filing |
| 17 Jan 2025filed 22 Jan 2025 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,638 at $0.00 | filing |
| 11 Jun 2024filed 13 Jun 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —217,677 at $0.00 | filing |
| 4 Mar 2024filed 6 Mar 2024 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —57,323 at $0.00 | filing |
| 28 Feb 2023filed 8 Mar 2023 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,000 at $0.00 | filing |
| 16 Dec 2022filed 19 Dec 2022 | CING Cingulateoption or derivative · Biotechnology | SEC FORM 4 Code P | $52200 at $0.26 | filing |
| 16 Dec 2022filed 19 Dec 2022 | CING CingulateBiotechnology | SEC FORM 4 Bought | $10K10,000 at $1.02 | filing |
News
No headline names them, or the companies they trade most, lately.